High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario, and development of advanced genomic analysis techniques for quality control during implant manufacturing are key factors contributing to high CAGR of Extremities (Shoulder and Small Combined Implants) during forecast...